CTRV

Contravir Pharmaceuticals Inc (CTRV)

Contravir Pharmaceuticals (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CTRV

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2019/11/08	20:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/11/08	02:56	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/10/24	05:30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/10/22	05:26	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/10/17	05:54	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/10/11	00:33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/10/09	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/10/04	05:21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/09/05	00:47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/09/04	05:40	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/08/15	06:30	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/08/14	22:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/08/08	02:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/08/01	02:42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/31	05:50	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/30	05:15	GlobeNewswire Inc.	Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/26	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/23	21:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/07/23	03:00	GlobeNewswire Inc.	ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/06/28	21:43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/06/27	22:54	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/06/27	21:00	GlobeNewswire Inc.	ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASH	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/06/21	05:30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
2019/06/21	05:30	GlobeNewswire Inc.	ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASH	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)